Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication. by Mead, A, Gale, R, Kottaridis, P, Matsuda, S, Khwaja, A, Linch, D

An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and respo... by Kottaridis, P, Ketley, N, Peggs, K, Chakraverty, R, Ralleigh, G, Shaw, P, Pezzella, F, Goldstone, A, Devereux, S, Mackinnon, S

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation. by Chakraverty, R, Robinson, S, Peggs, K, Kottaridis, P, Watts, M, Ings, S, Hale, G, Waldmann, H, Linch, D, Goldstone, A, Mackinnon, S

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation. by Chakraverty, R, Robinson, S, Peggs, K, Kottaridis, P, Watts, M, Ings, S, Hale, G, Waldmann, H, Linch, D, Goldstone, A, Mackinnon, S

Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation. by Mackinnon, S, Kottaridis, P, Perry, A, Chakrabarti, S, Milligan, D, Pettengell, R, Chopra, R, Morgan, G, Hale, G, Waldmann, H, Linch, D, Devereux, S, Goldstone, A

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. by Mead, A, Thomson, K, Morris, E, Mohamedbhai, S, Denovan, S, Orti, G, Fielding, A, Kottaridis, P, Hough, R, Chakraverty, R, Linch, D, Mackinnon, S, Peggs, K

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients fro... by Kottaridis, P, Gale, R, Frew, M, Harrison, G, Langabeer, SE, Belton, A, Walker, H, Wheatley, K, Bowen, D, Burnett, A, Goldstone, A, Linch, D

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the... by Kottaridis, P, Gale, R, Frew, M, Harrison, G, Langabeer, SE, Belton, A, Walker, H, Wheatley, K, Bowen, D, Burnett, A, Goldstone, A, Linch, D

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. by Chakrabarti, S, Avivi, I, Mackinnon, S, Ward, K, Kottaridis, P, Osman, H, Waldmann, H, Hale, G, Fegan, C, Yong, K, Goldstone, A, Linch, D, Milligan, D

A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. by Kottaridis, P, Chakraverty, R, Milligan, D, Chakrabarti, S, Robinson, S, Chopra, R, Pettengell, R, Marsh, J, Mahendra, P, Schey, S, Morgan, G, Williams, C, Hale, G, Waldmann, H, Linch, D, Devereux, S, Goldstone, A, Mackinnon, S

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. by Chakrabarti, S, Mackinnon, S, Chopra, R, Kottaridis, P, Peggs, K, O'Gorman, P, Chakraverty, R, Marshall, T, Osman, H, Mahendra, P, Craddock, C, Waldmann, H, Hale, G, Fegan, C, Yong, K, Goldstone, A, Linch, D, Milligan, D

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. by Kottaridis, P, Milligan, D, Chopra, R, Chakraverty, R, Chakrabarti, S, Robinson, S, Peggs, K, Verfuerth, S, Pettengell, R, Marsh, J, Schey, S, Mahendra, P, Morgan, G, Hale, G, Waldmann, H, Elvira, d, Williams, C, Devereux, S, Linch, D, Goldstone, A, Mackinnon, S

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. by Kottaridis, P, Milligan, D, Chopra, R, Chakraverty, R, Chakrabarti, S, Robinson, S, Peggs, K, Verfuerth, S, Pettengell, R, Marsh, J, Schey, S, Mahendra, P, Morgan, G, Hale, G, Waldmann, H, de Elvira, R, Williams, C, Devereux, S, Linch, D, Goldstone, A, MacKinnon, S

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. by Chakraverty, R, Peggs, K, Chopra, R, Milligan, D, Kottaridis, P, Verfuerth, S, Geary, J, Thuraisundaram, D, Branson, K, Chakrabarti, S, Mahendra, P, Craddock, C, Parker, A, Hunter, A, Hale, G, Waldmann, H, Williams, C, Yong, K, Linch, D, Goldstone, A, Mackinnon, S

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. by Craddock, C, Nagra, S, Peniket, A, Brookes, C, Buckley, L, Nikolousis, E, Duncan, N, Tauro, S, Yin, J, Liakopoulou, E, Kottaridis, P, Snowden, J, Milligan, D, Cook, G, Tholouli, E, Littlewood, T, Peggs, K, Vyas, P, Clark, F, Cook, M, Mackinnon, S, Russell, N

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. by Chakraverty, R, Orti, G, Roughton, M, Shen, J, Fielding, A, Kottaridis, P, Milligan, D, Collin, M, Crawley, C, Johnson, P, Clark, A, Parker, A, Bloor, A, Pettengell, R, Snowden, J, Pettitt, A, Clark, R, Hale, G, Peggs, K, Thomson, K, Morris, E, Mackinnon, S